CorriganJJFeigSA.American academy of pediatrics. Guidelines for pediatric cancer centers. Pediatrics2004;
113: 1833–1835.
2.
CejaMEChristensenAMYangSP.Dosing considerations in pediatric oncology. US Pharm2013;
38: 8–11.
3.
YismawMBAdamHEngidaworkE.Identification and resolution of drug-related problems among childhood cancer patients in Ethiopia. J Oncol2020;
2020: 6785835.
4.
DiopBBCheikhAAttjiouiH, et al.
Evaluation of anti-infectives prescriptions in a pediatric hemato-oncological center: a retrospective study. J Oncol Pharm Pract2019;
25: 1811–1816.
5.
DefoeKDJuppJLeslieT.Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic. J Oncol Pharm Pract2019;
25: 607–612.
6.
AliKAl-QuteimatONaseemR, et al. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: assessment and significance. J Oncol Pharm Pract. Epub Ahead of Print July 2020; 6. DOI: 10.1177/1078155220934167.
PhillipsRSFriendAJGibsonF, et al.
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood (review). Cochrane Database Syst Rev2016;
2: CD007786.
9.
PatelPRobinsonPDThackrayJ, et al.
Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: a focused update. Pediatr Blood Cancer2017;
64: e26542.
10.
SheraniFBostonCMbaN.Latest update on prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients. Curr Oncol Rep2019;
21: 89.
